MentionFox
Home › Executive changes › Cannapharmarx, Inc.
Leadership changes · CPMD · SEC Form 8-K, Item 5.02

Leadership changes at Cannapharmarx, Inc. (2026)

Before you join, sell to or invest in Cannapharmarx, Inc.

MentionFox check on Cannapharmarx, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/cannapharmarx

Check Cannapharmarx, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Cannapharmarx, Inc.?

Who joined and who left Cannapharmarx, Inc. (CPMD)? 1 departure reported on 2026-01-13, each cited to the company's own filing.

Rick Orman left the role of Director at Cannapharmarx, Inc. As of November 14, 2026, Cannapharmarx, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on January 13, 2026, naming 1 departure (Form 8-K, January 13, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Sell to companies like Cannapharmarx, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Out (departing)1
Latest filing2026-01-13

Cannapharmarx, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-01-13. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Cannapharmarx, Inc. files it.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-01-13OutDirector8-K, 2026-01-13

Selling to them or working with them? See who runs Cannapharmarx, Inc. now and the warning signs.

Free to see. No signup.

Want the whole picture on Cannapharmarx, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Cannapharmarx, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Cannapharmarx, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Why did they leave? What the filings say

Cannapharmarx, Inc.'s filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.

Who leads Cannapharmarx, Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Cannapharmarx, Inc.?

New leaders reset buying decisions — get the Full Report on Cannapharmarx, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Cannapharmarx, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the Director at Cannapharmarx, Inc., with the record behind each one.

Find candidates like Director at Cannapharmarx, Inc.

Every change, in the filing's words

Filed 2026-01-13 · 8-K

Departing: Rick Orman, Director

On January 8, Rick Orman informed the Board of Directors (the "Board") of CannaPharmaRx, Inc. (the "Company") of his resignation as a member of the Board effective immediately.

Tools for this story

Each opens in a new tab, filled in for Cannapharmarx, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/cannapharmarx
Last updated 2026-11-14
Primary record: SEC filing
Cannapharmarx, Inc. executive departure 2026. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/cannapharmarx